Dr Reddy’s asked to resubmit application for both phase 2,3 trials of Russian COVID-19 vaccine | India News,The Indian Express

Dr Reddy’s asked to resubmit application for both phase 2,3 trials of Russian COVID-19 vaccine | India News,The Indian Express

Dr Reddy’s asked to resubmit application for both phase 2,3 trials of Russian COVID-19 vaccine

OCTOBER 6, 2020 10:14:20 AM

Upon regulatory approval in India, RDIF shall supply to drug maker Dr Reddy's 100 million doses of the vaccine, the firm had said last month.